Anifrolumab 90112-3000
Product NDC
90112-3000- Manufacturer
- Astrazeneca Nijmegen B.v.
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- July 30, 2021
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Anifrolumab | 300 mg/2mL |
Packaging Options(1)
1105 VIAL, GLASS in 1 BOX (90112-3000-2) / 2 mL in 1 VIAL, GLASS